NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing complex products for niche therapeutic areas.
Financial Results:
- Natco Pharma Ltd. reported Total Income for Q4FY23 of ₹ 2,812 Crores up from ₹ 2,044 Crore year on year, a rise of 38%.
- Total Expenses for Q4FY23 of ₹ 1,950 Crores up from ₹ 1,842 Crores year on year, rise of 6%.
- Consolidated Net Profit of ₹ 715 Crores, up 321% from ₹ 170 Crores in the same quarter of the previous year.
- The Earnings per Share is ₹ 39.18, up 320% from ₹ 9.32 in the same quarter of the previous year.
Most Popular
Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript
Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah
All you need to know about Antony Waste Handling Cell in one article
Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?
Demystifying the Leading Non-Ferrous Recycling Company of India
“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,